Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Cornelian Cherry Supplementation in Patients With Metabolic Syndrome
Sponsor: Wroclaw Medical University
Summary
This randomized, double-blind, placebo-controlled, parallel-group study evaluated the effects of six-month oral supplementation with Cornus mas fruit lyophilizate in patients with metabolic syndrome. Participants were assigned to receive either 8 g of Cornus mas fruit lyophilizate once daily or a matching placebo. Ophthalmic assessments included best-corrected visual acuity, slit-lamp examination, dilated fundus examination, applanation tonometry, and Doppler ultrasonography of the ophthalmic, central retinal, and posterior ciliary arteries. Cardiometabolic and biochemical parameters were also assessed at baseline and after 3 and 6 months of supplementation.
Official title: Effect of Oral Lyophilized Cornelian Cherry (Cornus Mas L.) Fruit on Selected Cardiometabolic, Vascular, Gut, Ocular and Bone Metabolism Parameters in Patients With Metabolic Syndrome.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
55
Start Date
2019-01-17
Completion Date
2026-06-25
Last Updated
2026-07-31
Healthy Volunteers
No
Conditions
Interventions
Placebo
A matching placebo formulation containing potato starch and sugar but no Cornus mas fruit lyophilizate, administered orally once daily for 6 months as a preparation made into a jelly.
Cornus mas Fruit Lyophilizate
A dietary supplement containing 8 g of lyophilized whole Cornus mas L. fruit, administered orally once daily for 6 months as a powder or granulate formulation prepared as a jelly.
Locations (1)
Department of Pharmacology, Wroclaw Medical University
Wroclaw, Poland